These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses. Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621 [TBL] [Abstract][Full Text] [Related]
10. [Investigation of therapeutic and protective effect of Reaferon-ES Lipint on mice infected with avian influenza virus (subtype H5N1)]. Demina OK; Sergeev AA; Agafonov AP; Shikov AN; Sementsova AO; Sergeev AA; Sergeev AN; Drozdov IG Antibiot Khimioter; 2009; 54(9-10):27-9. PubMed ID: 20415260 [TBL] [Abstract][Full Text] [Related]
11. Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model. Hurt AC; Lowther S; Middleton D; Barr IG Antiviral Res; 2010 Sep; 87(3):361-6. PubMed ID: 20603155 [TBL] [Abstract][Full Text] [Related]
12. Antisense oligonucleotides targeting the RNA binding region of the NP gene inhibit replication of highly pathogenic avian influenza virus H5N1. Zhang T; Wang TC; Zhao PS; Liang M; Gao YW; Yang ST; Qin C; Wang CY; Xia XZ Int Immunopharmacol; 2011 Dec; 11(12):2057-61. PubMed ID: 21933722 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice. Liu Z; Guo Z; Wang G; Zhang D; He H; Li G; Liu Y; Higgins D; Walsh A; Shanahan-Prendergast L; Lu J Eur J Pharm Sci; 2009 Oct; 38(3):215-23. PubMed ID: 19616097 [TBL] [Abstract][Full Text] [Related]
14. Death Mechanisms of Pulmonary Alveolocytes in Mice Infected with Influenza Viruses A/H1N1/California/04/2009 and A/H5N1/Goose/Krasnoozerskoye/627/05. Cherdantseva LA; Kovner AV; Sharkova TV; Shkurupy VA; Shestopalov AM; Potapova OV Bull Exp Biol Med; 2019 Mar; 166(5):637-640. PubMed ID: 30903504 [TBL] [Abstract][Full Text] [Related]
15. Neuraminidase inhibitor resistance in influenza viruses. Reece PA J Med Virol; 2007 Oct; 79(10):1577-86. PubMed ID: 17705169 [TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of crude extracts of Eugenia jambolana Lam. against highly pathogenic avian influenza (H5N1) virus. Sood R; Swarup D; Bhatia S; Kulkarni DD; Dey S; Saini M; Dubey SC Indian J Exp Biol; 2012 Mar; 50(3):179-86. PubMed ID: 22439432 [TBL] [Abstract][Full Text] [Related]
17. Morphofunctional characteristics of fibroblasts and fibrogenesis in the lungs of mice infected with influenza A/H5N1 A/goose/Krasnoozerskoye/627/05 virus. Anikina AG; Potapova OV; Shkurupy VA Bull Exp Biol Med; 2013 Jan; 154(3):361-4. PubMed ID: 23484201 [TBL] [Abstract][Full Text] [Related]
18. Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo. Haasbach E; Droebner K; Vogel AB; Planz O J Interferon Cytokine Res; 2011 Jun; 31(6):515-25. PubMed ID: 21323570 [TBL] [Abstract][Full Text] [Related]
19. Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice. Belser JA; Szretter KJ; Katz JM; Tumpey TM Virology; 2013 Apr; 439(1):42-6. PubMed ID: 23453580 [TBL] [Abstract][Full Text] [Related]
20. [Prophylactic and therapeutic efficacies of Ingavirin, a novel Russian chemotherapeutic, with respect to influenza pathogen A (H5N1)]. Loginova SIa; Borisevich SV; Shkliaeva OM; Maksimov VA; Bondarev VP; Nebol'sin VE Antibiot Khimioter; 2010; 55(7-8):10-2. PubMed ID: 21140557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]